Connection
Richard Turnage to Enzyme Inhibitors
This is a "connection" page, showing publications Richard Turnage has written about Enzyme Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.118 |
|
|
|
-
Rath S, Kalogeris T, Mai N, Zibari G, Alexander JS, Lefer D, Turnage RH. Insulin prevents oxidant-induced endothelial cell barrier dysfunction via nitric oxide-dependent pathway. Surgery. 2006 Jan; 139(1):82-91.
Score: 0.056
-
Nwariaku FE, Chang J, Zhu X, Liu Z, Duffy SL, Halaihel NH, Terada L, Turnage RH. The role of p38 map kinase in tumor necrosis factor-induced redistribution of vascular endothelial cadherin and increased endothelial permeability. Shock. 2002 Jul; 18(1):82-5.
Score: 0.044
-
Nwariaku FE, Rothenbach P, Liu Z, Zhu X, Turnage RH, Terada LS. Rho inhibition decreases TNF-induced endothelial MAPK activation and monolayer permeability. J Appl Physiol (1985). 2003 Nov; 95(5):1889-95.
Score: 0.012
-
Myers SI, Turnage RH, Hernandez R, Castenada A, Valentine RJ. Autoregulation of renal and splanchnic blood flow following infra-renal aortic clamping is mediated by nitric oxide and vasodilator prostanoids. J Cardiovasc Surg (Torino). 1996 Apr; 37(2):97-103.
Score: 0.007